Material Agreements

Nissan Auto Receivables 2026-A Owner Trust entered into Asset Representations Review Agreement dated as of the Closing Date with Clayton Fixed Income Services LLC valued at Review of certain representations relating to the Receivables (effective 2026-05-27).

“On the Closing Date, the Issuing Entity, as issuer, NMAC, as sponsor and servicer, and Clayton Fixed Income Services LLC, as asset representations reviewer, entered into that certain Asset Representations Review Agreement, dated as of the Closing Date (the "Asset Representations Review Agreement"), relating to the review of certain representations relating to the Receivables.”

Nissan Auto Receivables 2026-A Owner Trust entered into Amended and Restated Trust Agreement dated as of the Closing Date with Wilmington Trust, National Association, as owner trustee; U.S. Bank Trust Company, National Association, as certificate registrar and certificate paying agent valued at Establishment of Issuing Entity as a Delaware statutory trust (effective 2026-05-27).

“On the Closing Date, Nissan Auto Receivables 2026-A Owner Trust (the "Issuing Entity"), a Delaware statutory trust established by a Trust Agreement dated as of April 9, 2026, as amended and restated by an Amended and Restated Trust Agreement dated as of the Closing Date (the "Amended and Restated Trust Agreement"), by and between NARC II, as depositor, Wilmington Trust, National Association, as owner trustee”

Nissan Auto Receivables 2026-A Owner Trust entered into Sale and Servicing Agreement dated as of the Closing Date with Nissan Motor Acceptance Company LLC, U.S. Bank Trust Company, National Association valued at Transfer of receivables to Issuing Entity; servicing arrangement (effective 2026-05-27).

“entered into that certain Sale and Servicing Agreement, dated as of the Closing Date (the "Sale and Servicing Agreement"), with NARC II, as seller, NMAC, as servicer, and U.S. Bank Trust Company, National Association, as indenture trustee”

Nissan Auto Receivables 2026-A Owner Trust entered into Purchase Agreement dated as of the Closing Date with Nissan Motor Acceptance Company LLC valued at Purchase of retail motor-vehicle installment sales contracts and related property (effective 2026-05-27).

“On May 27, 2026 (the "Closing Date"), Nissan Auto Receivables Company II LLC ("NARC II") and Nissan Motor Acceptance Company LLC ("NMAC") entered into that certain Purchase Agreement, dated as of the Closing Date (the "Purchase Agreement"), pursuant to which NMAC transferred to NARC II certain retail motor-vehicle installment sales contracts relating to certain new, near-new and used automobiles and light-duty trucks (the "Receivables") and related property.”

Nissan Auto Receivables 2026-A Owner Trust entered into Indenture dated as of the Closing Date with U.S. Bank Trust Company, National Association, as indenture trustee valued at $260,000,000 Class A-1, $240,000,000 Class A-2a, $198,130,000 Class A-2b, $438,130,000 Class A-3, $9 (effective 2026-05-27).

“Also on the Closing Date, the Issuing Entity caused the issuance, pursuant to an Indenture, dated as of the Closing Date (the "Indenture"), by and between the Issuing Entity, as issuer, and the Indenture Trustee, of $260,000,000 aggregate principal amount of Class A-1 Asset Backed Notes, $240,000,000 aggregate principal amount of Class A-2a Asset Backed Notes, $198,130,000 aggregate principal amount of Class A-2b Asset Backed Notes, $438,130,000 aggregate principal amount of Class A-3 Asset Backed Notes, $93,750,000 aggregate principal amount of Class A-4 Asset Backed Notes, $21,140,000 aggregate principal amount of Class B Asset Backed Notes and $17,300,000 aggregate principal amount of Class C Asset Backed Notes (collectively, the "Notes").”

Nissan Auto Receivables 2026-A Owner Trust entered into Underwriting Agreement dated as of May 20, 2026 with Wells Fargo Securities, LLC, MUFG Securities Americas Inc., Mizuho Securities USA LLC, U.S. Bancorp Investments, Inc., BNP Paribas Securities Corp., BofA Securities, Inc., Citigroup Global Markets Inc., Lloyds Securities Inc. valued at Notes with an aggregate principal balance of $1,268,450,000 (effective 2026-05-20).

“The Notes, with an aggregate principal balance of $1,268,450,000, were sold to Wells Fargo Securities, LLC, MUFG Securities Americas Inc., Mizuho Securities USA LLC, U.S. Bancorp Investments, Inc., BNP Paribas Securities Corp., BofA Securities, Inc., Citigroup Global Markets Inc., and Lloyds Securities Inc. (together, the "Underwriters") pursuant to an Underwriting Agreement, dated as of May 20. 2026, by and among NARC II, NMAC and Wells Fargo Securities, LLC, on behalf of itself and as the representative of the Underwriters.”

IIOT-OXYS, Inc. amended Extension No. 7 to Convertible Promissory Note with GHS Investments LLC valued at Maturity date extended to October 31, 2026; prior Events of Default waived (effective 2026-05-21).

“On May 21, 2026, the Company entered into Extension No. 7 to the Note (the " Extension ") with GHS, pursuant to which the maturity date of the Note was extended to October 31, 2026 (the "Maturity Date").”

CNH Equipment Trust 2026-B entered into Transaction Documents with Wells Fargo Securities, LLC, Rabo Securities USA, Inc., RBC Capital Markets, LLC and SMBC Nikko Securities America, Inc. valued at $190,000,000 of Class A-1 Asset Backed Notes, $246,540,000 of Class A-2a and $105,660,000 of Class A (effective 2026-05-27).

“On May 27, 2026, CNH Equipment Trust 2026-B (the “Trust”) publicly issued $190,000,000 of Class A-1 Asset Backed Notes (the “Class A-1 Notes”), $246,540,000 of Class A-2a and $105,660,000 of Class A-2b Asset Backed Notes (together, the “Class A-2 Notes”), $302,200,000 of Class A-3 Asset Backed Notes (the “Class A-3 Notes”), and $63,280,000 of Class A-4 Asset Backed Notes (the “Class A-4 Notes” and together with the Class A-1 Notes, the Class A-2 Notes, and the Class A-3 Notes, the “Notes”)”

NewHold Investment Corp. III entered into Business Combination Agreement with NewCleo Ltd., newcleo1 Ltd., newcleo2 Ltd. (effective 2026-05-26).

“On May 26, 2026, NewHold Investment Corp III, a Cayman Islands exempted company with limited liability (the “ SPAC ” or “ NewHold ”), entered into a Business Combination Agreement (the “ Business Combination Agreement ”) with NewCleo Ltd., a private limited company incorporated under the laws of England and Wales”

New Horizon Aircraft Ltd. entered into Placement Agency Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (effective 2026-05-26).

“In connection with the Offering, the Company entered into a Placement Agency Agreement, dated as of May 26, 2026, with Titan Partners Group LLC, a division of American Capital Partners, LLC (the “Placement Agent”), pursuant to which the Placement Agent agreed to serve as the sole placement agent for the issuance and sale of the Securities pursuant to the Purchase Agreements.”

New Horizon Aircraft Ltd. entered into Purchase Agreements with certain institutional investors valued at aggregate gross proceeds to the Company from the Offering of approximately $25.0 million (effective 2026-05-26).

“On May 26, 2026, New Horizon Aircraft Ltd. (the “Company”) entered into Securities Purchase Agreements (the “Purchase Agreements”) with certain institutional investors, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the “Offering”) an aggregate of (i) 5,385,646 our Class A ordinary shares, without par value (the “Shares”, and each Class A ordinary share with no par value in the authorized share structure of the Company, a “Common Share”) and (ii) pre-funded warrants (the “Pre-Funded Warrants”, and together with the Shares, the “Securities”) to purchase 4,574,514 Common Shares (such Common Shares, the “Pre-Funded Warrant Shares”).”

DigitalBridge Group, Inc. entered into ArcLight Agreement with ArcLight Capital Holdings, LLC valued at Acquisition of ArcLight for aggregate purchase price of $650 million, subject to post-closing adjust (effective 2026-05-23).

“On May 23, 2026 (the “ Signing Date ”), DigitalBridge Group, Inc., a Maryland corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ ArcLight Agreement ”) with DigitalBridge Operating Company, LLC, a Delaware limited liability company (“ Company OP ”), DB Marley Sub, LLC, a Delaware limited liability company (“ Merger Sub ”), ArcLight Capital Holdings, LLC, a Delaware limited liability company (“ ArcLight ”), ACHP II, L.P., a Delaware limited partnership, in its capacity as managing member of ArcLight (“ ACHP II ”), and Daniel R. Revers, in his capacity as the representative of the Company Owners (as defined in the ArcLight Agreement) (the “ Seller Representative ”).”

La Rosa Holdings Corp. entered into Securities Purchase Agreement with an institutional investor valued at $250,000 (effective 2026-05-27).

“On May 27, 2026, La Rosa Holdings Corp., a Nevada corporation (the " Company "), and an institutional investor (the " Investor ") entered into a Securities Purchase Agreement (the " SPA ")”

Cheniere Energy, Inc. entered into Purchase Agreement with BofA Securities, Inc., as representative of the initial purchasers valued at $1 billion aggregate principal amount of its 5.350% Senior Notes due 2036 and $750 million aggregate (effective 2026-05-26).

“On May 26, 2026, Cheniere Energy Partners, L.P. (“Cheniere Partners”), a subsidiary of Cheniere Energy, Inc. (“Cheniere”), and each of Cheniere Energy Investments, LLC, Sabine Pass LNG-GP, LLC, Sabine Pass LNG, L.P., Sabine Pass Tug Services, LLC, Cheniere Creole Trail Pipeline, L.P. and Cheniere Pipeline GP Interests, LLC, as guarantors, entered into a Purchase Agreement (the “Purchase Agreement”) with BofA Securities, Inc., as representative of the initial purchasers named therein (the “Initial Purchasers”), to issue and sell to the Initial Purchasers $1 billion aggregate principal amount of its 5.350% Senior Notes due 2036 (the “2036 Notes”) and $750 million aggregate principal amount of its 6.050% Senior Notes due 2056 (the “2056 Notes”, and, together with the 2036 Notes, the “Notes”).”

BNB PLUS CORP. entered into Warrant Inducement and Exchange Agreement with certain investors who participated in 2025 PIPE (effective 2026-05-26).

“(2) Warrant Inducement and Exchange Agreements (each an “Inducement Agreement”), with certain investors (each an “Exchanging Holder”) who participated in the Company’s private placements that closed on October 3, 2025 and October 23, 2025 (collectively the “2025 PIPE”)”

BNB PLUS CORP. entered into Securities Purchase Agreement with accredited investors valued at up to an aggregate amount of $5 million (effective 2026-05-26).

“On May 26, 2026, BNB Plus Corp., a Delaware corporation (the “Company”), entered into agreements to issue in one or more offerings up to an aggregate amount of $5 million (the “Aggregate Offering Amount”) of the Company’s securities in a convertible preferred equity private placement financing pursuant to: (1) a Securities Purchase Agreement (the “SPA”) with accredited investors (“Purchasers”)”

Cheniere Energy Partners, L.P. entered into Purchase Agreement with BofA Securities, Inc., as representative of the initial purchasers named therein valued at $1 billion aggregate principal amount of its 5.350% Senior Notes due 2036 and $750 million aggregate (effective 2026-05-26).

“On May 26, 2026, Cheniere Energy Partners, L.P. (“Cheniere Partners”) and each of Cheniere Energy Investments, LLC, Sabine Pass LNG-GP, LLC, Sabine Pass LNG, L.P., Sabine Pass Tug Services, LLC, Cheniere Creole Trail Pipeline, L.P. and Cheniere Pipeline GP Interests, LLC, as guarantors, entered into a Purchase Agreement (the “Purchase Agreement”) with BofA Securities, Inc., as representative of the initial purchasers named therein (the “Initial Purchasers”), to issue and sell to the Initial Purchasers $1 billion aggregate principal amount of its 5.350% Senior Notes due 2036 (the “2036 Notes”) and $750 million aggregate principal amount of its 6.050% Senior Notes due 2056”

MIRA PHARMACEUTICALS, INC. amended Amendment No. 1 to Exclusive License Agreement with MIRALOGX LLC valued at Expanded exclusive licensed territory from US, Canada, Mexico to all countries with patent rights; e (effective 2026-05-21).

“On May 21, 2026, MIRA Pharmaceuticals, Inc. (the “Company”) entered into Amendment No. 1 (the “Amendment”) to that certain Exclusive License Agreement, effective November 15, 2023, by and between the Company and MIRALOGX LLC.”

HCW Biologics Inc. terminated License with Wugen Inc. (effective 2026-05-21).

“On May 27, 2026, HCW Biologics Inc. (the “Company”) issued a press release announcing that on May 21, 2026, the Company elected to exercise its option to terminate the exclusive worldwide license agreement with Wugen Inc. (the “License”) for ex vivo rights to the Company’s molecules HCW9201 and HCW9206.”

Translational Development Acquisition Corp. entered into Business Combination Agreement with Prologium Holding Inc., PLG Merger Sub 1, and PLG Merger Sub 2 valued at approximately $3.8 billion valuation (effective 2026-05-27).

“On May 27, 2026, Translational Development Acquisition Corp., a Cayman Islands exempted company with limited liability (“TDAC”), entered into an Agreement and Plan of Merger (as it may be amended, restated or otherwise modified from time to time, the “Business Combination Agreement”) with Prologium Holding Inc., a Cayman Islands exempted company with limited liability (“ProLogium” or the “Company”), PLG Merger Sub 1, a Cayman Islands exempted company with limited liability and a wholly-owned direct subsidiary of the Company (“Merger Sub 1”), and PLG Merger Sub 2, a Cayman Islands exempted company with limited liability and a wholly-owned direct subsidiary of the Company (“Merger Sub 2” and, together with Merger Sub 1, the “Acquisition Entities”).”

Apogee Therapeutics, Inc. entered into Revenue Share Agreement with Annapurna Aggregator L.P., an affiliate of funds managed by Blackstone Life Sciences valued at $100.0 million upfront payment (effective 2026-05-26).

“On May 26, 2026 (the “Effective Date”), Apogee Therapeutics, Inc. (the “Company”) entered into a revenue participation right purchase and sale agreement (the “Revenue Share Agreement”) with Annapurna Aggregator L.P., an affiliate of funds managed by Blackstone Life Sciences (“BXLS”).”

Data Storage Corp entered into Equity Distribution Agreement with Maxim Group LLC (effective 2026-05-26).

“On May 26, 2026, Data Storage Corporation (the “Company”) entered into an Equity Distribution Agreement (the “Agreement”), with Maxim Group LLC (“Maxim”), pursuant to which the Company may offer and sell, from time to time, through Maxim, as sales agent or principal, shares of its common stock”

Bain Capital Private Credit entered into New Commitment Request with Goldman Sachs Bank USA valued at from $200,000,000 to $250,000,000 (effective 2026-05-21).

“On May 21, 2026, BCPC I, LLC (the “Borrower”) entered into a New Commitment Request (the “New Commitment Request”) among the Borrower, and Goldman Sachs Bank USA, as administrative agent and lender, pursuant to that certain Credit Agreement, dated as of November 29, 2023 (as amended, supplemented or otherwise modified, the “Revolving Credit Facility”)”

CALLAN JMB INC. entered into Sales Agreement with Alexander Capital, L.P. valued at up to $5,000,000 (effective 2026-05-26).

“On May 26, 2026, Callan JMB Inc. (the “Company”) entered into an At-The-Market Issuance Sales Agreement (the “Sales Agreement”) with Alexander Capital, L.P. (“Alexander Capital”), as sales agent, pursuant to which the Company may offer and sell, from time to time, through Alexander Capital shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $5,000,000.”

Cycurion, Inc. entered into Agreement and Plan of Merger with Halo Privacy, Inc. and havenX, Inc. (effective 2026-05-07).

“On May 7, 2026, Cycurion, Inc., a Delaware corporation (“Parent”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Cycurion Merger Sub-Halo, Inc. (“Merger Sub-Halo”), Cycurion Merger Sub-havenX, Inc. (“Merger Sub-havenX”), Halo Privacy, Inc., a Delaware corporation (“Halo”), havenX, Inc., a Wyoming corporation (“havenX”), and Shareholder Representative Services LLC, solely in its capacity as the Company Group Equityholder Representative (the “Equityholder Representative”).”

Angel Oak Financial Strategies Income Term Trust entered into Note Purchase Agreement with the purchaser named therein valued at $40 million (effective 2026-05-22).

“On May 22, 2026, the Fund entered into a notes purchase agreement (the “Note Purchase Agreement”), by and among the Fund and the purchaser named therein (the “Note Purchaser”), in connection with the private offering of the Fund’s 5.364% Series C Senior Notes, due July 8, 2030 (the “Series C Notes”), in a transaction exempt from registration under the Securities Act of 1933, as amended (the “Note Placement”). The Series C Notes bear a fixed interest rate of 5.364% per year and mature on July 8, 2030, unless redeemed, purchased or repaid prior to such date by FINS in accordance with their terms. The Fund will receive gross proceeds from the sale of Series C Notes of $40 million.”

Angel Oak Financial Strategies Income Term Trust entered into Securities Purchase Agreement with the purchaser named therein valued at $50 million (effective 2026-05-22).

“On May 22, 2026, Angel Oak Financial Strategies Income Term Trust (NYSE: FINS) (the “Fund”) entered into a securities purchase agreement (the “Securities Purchase Agreement”), by and among the Fund and the purchaser named therein (the “Securities Purchaser”), in connection with the issuance and sale of 2,000,000 shares of the Fund’s Series A Mandatorily Redeemable Preferred Shares, due April 30, 2031, liquidation preference of $25.00 (the “MRPS”), in a transaction exempt from registration under the Securities Act of 1933, as amended (the “Preferred Placement”). The Fund received gross proceeds from the sale of the MRPS of $50 million.”

IREN Ltd entered into Dell Purchase Agreement with Dell Marketing L.P. valued at approximately $1.6 billion (effective 2026-05-19).

“On May 19, 2026, IE US Hardware 4 Inc. (“IE US Hardware”), a wholly owned subsidiary of IREN Limited (the “Company”), and Dell Marketing L.P. (“Dell”) entered into purchase documentation (the “Dell Purchase Agreement”) pursuant to which Dell will supply to IE US Hardware GPUs and ancillary products and services (“GPUs”) for an aggregate purchase price of approximately $1.6 billion”

Toppoint Holdings Inc. entered into Securities Purchase Agreement with certain investors valued at $0.83 per share, for aggregate gross proceeds to the Company of $4,150,000 (effective 2026-05-19).

“On May 19, 2026, Toppoint Holdings Inc., a Nevada corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors (collectively, the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers, in a private placement, an aggregate of 5,000,000 shares of the Company’s common stock, par value $0.0001 per share (the “Shares”), at a purchase price of $0.83 per share, for aggregate gross proceeds to the Company of $4,150,000.”

CNL Strategic Residential Credit, Inc. amended First Amendment with Valley National Bank valued at $15 million (effective 2026-05-22).

“On May 22, 2026, CNL Strategic Residential Credit, Inc. (the “Company”) and Valley National Bank, a Tennessee banking corporation, (referred to as “Valley National Bank”) entered into a First Amendment (“First Amendment”) to the Loan and Security Agreement (the “Loan Agreement”) previously entered into by such parties for a fifteen million dollar ($15 million) revolving line of credit (the “Line of Credit”).”

Kiniksa Pharmaceuticals International, plc entered into Deed with Baker Bros. Advisors LP, on behalf of each of Baker Brothers Life Sciences, L.P. and 667, L.P. (the "Shareholders") (effective 2026-05-21).

“On May 21, 2026, Kiniksa Pharmaceuticals International, plc (the “Company”) entered into a deed of waiver (the “Deed”) with Baker Bros. Advisors LP, on behalf of each of Baker Brothers Life Sciences, L.P. and 667, L.P. (the “Shareholders”), pursuant to which the Shareholders waived their rights to convert any of their Class A1 or Class B1 ordinary shares into Class A or Class B ordinary shares (“Conversion Rights”) if, immediately prior to or following such conversion, the Shareholders would beneficially own more than 49.9% of the Company’s outstanding voting rights.”

Editas Medicine, Inc. entered into Underwriting Agreement with Cantor Fitzgerald & Co. and Wells Fargo Securities, LLC valued at combined public offering price of $2.25 (effective 2026-05-26).

“On May 26, 2026, Editas Medicine, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Cantor Fitzgerald & Co. and Wells Fargo Securities, LLC as representatives of the underwriters named therein (the “Underwriters”), relating to an underwritten public offering of 55,555,556 shares”

Future FinTech Group Inc. entered into Pre-Paid Purchase #3 with Avondale Capital, LLC valued at $2,000,000 in cash proceeds (effective 2026-05-20).

“On May 20, 2026, the Company entered into Pre-Paid Purchase #3 (the “Pre-Paid Purchase #3”) with the investor, pursuant to the Pre-Paid SPA.”

LIQTECH INTERNATIONAL INC entered into Note Purchase Agreement with affiliates of Bleichroeder L.P. and Laurence W. Lytton valued at Aggregate principal amount of $1.1 million of 9.09% original discount promissory notes; proceeds $1, (effective 2026-05-22).

“On May 22, 2026, LiqTech International, Inc. (the “Company”) issued and sold 9.09% original discount promissory notes in an aggregate principal amount of $1.1 million (the “Notes”) to affiliates of Bleichroeder L.P. and Laurence W. Lytton (together, the “Investors”), pursuant to a note purchase agreement entered into with the Investors (the “Note Purchase Agreement”).”

STARWOOD PROPERTY TRUST, INC. entered into Indenture with The Bank of New York Mellon valued at $600 million (effective 2026-05-26).

“On May 26, 2026, Starwood Property Trust, Inc., a Maryland corporation (the “Company”), closed its private offering of $600 million aggregate principal amount of its 6.125% unsecured senior notes due 2031 (the “Notes”), which priced on May 11, 2026. The Notes were issued under an indenture, dated as of May 26, 2026 (the “Indenture”), between the Company and The Bank of New York Mellon, as trustee.”

Bleichroeder Acquisition Corp. II amended SPA Amendment with Inflection Point Asset Management LLC valued at $250.0 million (effective 2026-05-23).

“On May 23, 2026, Parent, Parent Merger Sub, Inflection Point Asset Management LLC (“ Inflection Point ”) and an accredited investor advised by Inflection Point (the “ New Purchaser ”), entered into Amendment No. 1 (the “ SPA Amendment ”) to that certain Securities Purchase Agreement, dated as of March 4, 2026 (the “ SPA ”)”

Bleichroeder Acquisition Corp. II amended Amendment and Assignment Agreement with Pasqal Holding SAS (effective 2026-05-26).

“On May 26, 2026, Parent, Parent Merger Sub, Bleichroeder Acquisition France Merger Sub 2, a société anonyme formed under the laws of the Republic of France (“ New Merger Sub ”), and Pasqal entered into Amendment No. 1 to the Agreement and Plan of Merger and Assignment and Assumption Agreement (the “ Amendment and Assignment Agreement ”).”

WORLD ACCEPTANCE CORP amended Consent and Limited Modification to Fixed Charge Ratio with Bank of Montreal (effective 2026-05-22).

“On May 22, 2026, World Acceptance Corporation (the "Company") entered into a Consent and Limited Modification to Fixed Charge Ratio (the "Modification") with Bank of Montreal ("BMO"), as Administrative Agent and Collateral Agent, and the Required Lenders party to the Revolving Credit Agreement dated as of July 22, 2025 (as amended or otherwise modified from time to time, the "Credit Agreement"), by and among the Company, the lenders from time to time party thereto, and BMO, as Administrative Agent and Collateral Agent.”

Shimmick Corp entered into Underwriting Agreement with Roth Capital Partners, LLC valued at underwritten public offering of 3,730,000 shares of common stock at $3.50 per share; net proceeds ap (effective 2026-05-22).

“On May 22, 2026, Shimmick Corporation (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Roth Capital Partners, LLC, as the underwriter named therein (the “Underwriter”), in connection with an underwritten public offering of 3,730,000 shares of the Company’s common stock, par value $0.01 per share (the “Shares”), at a public offering price of $3.50 per Share.”

BlackRock Monticello Debt Real Estate Investment Trust amended First Amendment to Revolving Credit Agreement with JPMorgan Chase Bank, N.A. valued at maturity date extended to May 20, 2027; applicable margin modified (effective 2026-05-21).

“On May 21, 2026, BlackRock Monticello Debt Real Estate Investment Trust (the "Company") and JPMorgan Chase Bank, N.A. ("JPM") entered into the First Amendment to Revolving Credit Agreement (the "First Amendment"), amending that certain Credit Agreement, dated as of May 22, 2025, between the Company and JPM (as amended or otherwise modified from time to time, the "JPM Credit Agreement").”

NL INDUSTRIES INC entered into Plan of Merger (effective 2026-05-19).

“NL Industries, Inc., a New Jersey corporation (the “Predecessor Corporation”), and its wholly-owned subsidiary NLI Holdings, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger dated as of May 19, 2026 (the “Plan of Merger”), providing for the merger of the Predecessor Corporation with and into the Company”

COGENT COMMUNICATIONS HOLDINGS, INC. entered into Purchase Agreement with an affiliate of I Squared Capital valued at $225 million (effective 2026-05-22).

“On May 22, 2026, Cogent Fiber, LLC, a Delaware limited liability company (the “Seller”) and an indirect wholly owned subsidiary of Cogent Communications Holdings, Inc. (the “Company”), entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with an affiliate of I Squared Capital (the “Buyer”).”

URBAN OUTFITTERS INC amended Fifth Amendment to Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, and J.P. Morgan Securities LLC and Wells Fargo Bank, National Association, as joint lead arrangers and co-book managers valued at Extended maturity date to May 2031, removed Canadian Sublimit; borrowing base of up to $350 million (effective 2026-05-19).

“On May 19, 2026, Urban Outfitters, Inc. (the “Company”) and certain of its domestic subsidiaries entered into the fifth amendment (the “Fifth Amendment”) to the Company’s amended and restated credit agreement (the “Amended Credit Agreement”), amending the Company’s asset-based revolving credit facility with certain lenders, including JPMorgan Chase Bank, N.A., as administrative agent, and J.P. Morgan Securities LLC and Wells Fargo Bank, National Association, as joint lead arrangers and co-book managers.”

ASSEMBLY BIOSCIENCES, INC. entered into Underwriting Agreement with Guggenheim Securities, LLC and UBS Securities LLC, as representatives of the several underwriters valued at approximately $107.4 million (effective 2026-05-21).

“On May 21, 2026, Assembly Biosciences, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Guggenheim Securities, LLC ("Guggenheim Securities") and UBS Securities LLC, as representatives of the several underwriters listed in Schedule A thereto (the "Underwriters"), in connection with the issuance and sale, in an underwritten, registered offering (the "Offering"), of: (1) 3,358,602 shares (the "Offering Shares") of the Company's common stock, par value $0.001 per share (the " Common Stock "), at an offering price of $26.50 per share; and (2) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 415,000 shares of Common Stock (the "Pre-Funded Warrant Shares"), at an offering price of $26.499 per Pre-Funded Warrant.”

TEN Holdings, Inc. entered into Registration Rights Agreement with the Investor valued at required to register for resale the Shares (effective 2026-05-22).

“On May 22, 2026, in connection with the Purchase Agreement, the Company also entered into a registration rights agreement with the Investor (the “ Registration Rights Agreement ”), requiring the Company to register for resale the Shares by filing with the SEC a resale registration statement under the Securities Act within thirty days following the date of the Purchase Agreement.”

TEN Holdings, Inc. entered into Stock Purchase Agreement with the Investor valued at 500,000 shares of common stock for gross proceeds of approximately $500,000 (effective 2026-05-22).

“On May 22, 2026, TEN Holdings, Inc. (the “ Company ”) entered into a Stock Purchase Agreement (the “ Purchase Agreement ”) with the purchaser named therein (the “ Investor ”), pursuant to which the Company issued 500,000 shares (the “ Shares ”) of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), for gross proceeds of approximately $500,000.”

Viridian Therapeutics, Inc.\DE entered into Commercial Manufacturing Services Agreement with WuXi Biologics (Hong Kong) Limited (effective 2026-05-24).

“On May 24, 2026, Viridian Therapeutics, Inc. (the “Company”) entered into a Commercial Manufacturing Services Agreement (the “Agreement”) with WuXi Biologics (Hong Kong) Limited (“WuXi Biologics”) pursuant to which WuXi Biologics will manufacture and supply the Company’s anticipated long-term supply requirements of veligrotug drug substance and drug product for commercial use (the “Product”), if approved.”

Lamb Weston Holdings, Inc. terminated 2022 Facility Agreement with HSBC Bank (China) Company Limited, Shanghai Branch (effective 2026-05-22).

“On May 22, 2026, the 2022 Facility was repaid and terminated in connection with LW Ulanqab’s borrowing under the Term Loan Facility.”

Lamb Weston Holdings, Inc. entered into New Facility Agreement with HSBC Bank (China) Company Limited, Shanghai Branch valued at RMB 700,000,000 (approximately USD 102,940,000 equivalent) (effective 2026-05-19).

“(the “Company”), entered into a Facility Agreement (the “New Facility Agreement”) with the financial institutions party thereto and HSBC Bank (China) Company Limited, Shanghai Branch, as the facility agent (the “Facility Agent”), providing for an RMB 700,000,000 (approximately USD 102,940,000 equivalent as of May 19, 2026 based on prevailing exchange rates on that date) term loan facility (the “Term Loan Facility”).”

Profusa, Inc. entered into First Amendment to Asset Purchase Agreement with Bio Insights LLC valued at $30,000,000 (effective 2026-05-22).

“On May 22, 2026, Profusa Inc., a Delaware corporation (the “Company”), and Bio Insights LLC, a limited liability company (“Seller”), entered into a First Amendment to the Asset Purchase Agreement (the “Amendment”), amending that certain Asset Purchase Agreement, dated as of April 21, 2026 (the “Asset Purchase Agreement”), by and between the Company and Seller.”